Sweden: Jonebrant takes on acting CFO role at Isofol Medical as Albèrt departs – LaingBuisson News

[ad_1] Isofol Medical, which is developing the drug candidate arfolitixorin with the aim of increasing the efficacy of current standard treatments for colorectal cancer and certain other tumour diseases, has…